SHMT2 and hepatocellular carcinoma: In agreement with our results, SIRT5 was found to drive HEK293 cancer cell proliferation via desuccinylation and activation of the serine hydroxymethyltransferase SHMT2 (35) and promote cell proliferation in HCC by targeting E2F transcription factor 1 (14).